Nucletron, an Elekta company, reaches major milestone with its brachytherapy treatment planning software
"We chose Flexitron because it is a highly advanced brachytherapy platform that met all our requirements"
Michael F. Sarosdy, MD, is convinced that brachytherapy is a far better choice than surgery for most men with prostate cancer